Results 161 to 170 of about 242,018 (254)

BCR–ABL1 Drives Transcriptional Reprogramming of Chronic Myeloid Leukemia Cells for Immune Evasion Through C/EBPβ

MedComm, Volume 7, Issue 5, May 2026.
There is global immunosuppression during CML initiation and progression, which is directly driven by BCR–ABL1 expressing CML cells. On one hand, the BCR–ABL1 oncogene drives the differentiation of leukemia cells toward the neutrophil lineage. On the other hand, the oncogene also transcriptionally activates master immune regulators, including arginase ...
Xiaocui Lu, Hui Fang, Yuan Liu, Chang Liu, Xuexiu Fang, Atsuko Matsunaga, Stephanie F. Mori, Ting Zhang, Gavin Wang, George I. Zhou, Miao Yu, Haocheng Ding, Jorge Cortes, Bo Cheng, Tianxiang Hu   +14 more
wiley   +1 more source

Immunogenetic Architecture of Chronic Lymphocytic Leukemia at Early Stage: Insights from the O-CLL1 Cohort. [PDF]

Antibodies (Basel)
Bagnara D, Mazzarello AN, Colombo M, Nano E, Cardente N, Ferrero F, Bertola N, Cossu V, Ghiotto F, Ibatici A, Angelucci E, Neri A, Gentile M, Morabito F, Ferrarini M, Cutrona G, Fais F.   +16 more
europepmc   +1 more source

CLL

Journal of Science, Humanities and Arts - JOSHA, 2017
openaire   +1 more source

Dynamics of Nerve Conduction Studies in Patients With Guillain–Barré Syndrome

Muscle &Nerve, Volume 73, Issue 5, Page 832-842, May 2026.
ABSTRACT Introduction/Aims The value of electrodiagnostic subtyping of Guillain–Barré syndrome (GBS) is still debated. This study aimed to determine the diagnostic yield, timing, and changes of the electrodiagnostic subtyping in patients with GBS in serial nerve conduction studies (NCS).
Samuel Arends, Laura de Koning, Judith Drenthen, Mahova Zhu, Peter Y. K. van den Bergh, Robert M. Hadden, Nortina Shahrizaila, Ricardo C. Reisin, Satoshi Kuwabara, Senda Ajroud‐Driss, Giovanni Antonini, Claudia Balducci, Fabio A. Barroso, Thomas H. Brannagan, Jan Buermann, Carlos Casasnovas, Guido Cavaletti, Chi‐Chao Chao, Ulrich Dillmann, Mazen M. Dimachkie, Giuliana Galassi, Gerardo Gutiérrez‐Gutiérrez, Thomas Harbo, Sung‐Tsang Hsieh, Badrul Islam, Hans Katzberg, Lynette Kiers, Giorgia Mataluni, Julio Pardo, Yann Peréon, Yusuf A. Rajabally, Mark Stettner, Camiel Verhamme, Michal Vytopil, Waheed Waqar, David R. Cornblath, Bart C. Jacobs, IGOS Consortium, James M. Addington, Senda Ajroud‐Driss, Hiroshi Amino, Giovanni Antonini, Sharam Attarian, Umesh A. Badrising, Claudia Balducci, Fabio A. Barroso, Kathleen Bateman, Isabelita Bella, Luana Benedetti, Tulio Bertorini, Ratna Bhavaraju‐Sanka, Davide Binda, Thomas Brannagan, Chiara Briani, Jan Buermann, Mark Busby, Steven Butterworth, Carlos Casasnovas, Guido Cavaletti, Govind Chavada, Chi‐Chao Chao, Shan Chen, Kristl Claeys, Eugenia Conti, Jeremy S. Cosgrove, Marinos Dalakas, Philip van Damme, Efthimios Dardiotis, Amy Davidson, Ulrich Dillmann, Mazen Dimachkie, Alex Doets, Pieter van Doorn, Andoni Echaniz‐Laguna, Filip Eftimov, Karin G. Faber, Raffaella Fazio, Thomas E. Feasby, Janev Fehmi, Chris Fokke, Toshiki Fujioka, Ernesto Fulgenzi, Giuliana Galassi, Marcel P.J. Garssen, Cees J. Gijsbers, James M. Gilchrist, Job Gilhuis, Jonathan M. Goldstein, Kenneth C. Gorson, Namita Goyal, Volkan Granit, Gerardo Gutiérrez‐Gutiérrez, Ludwig Gutmann, Thomas Harbo, Hans‐Peter Hartung, James K.L. Holt, Sung‐Tsang Hsieh, Min Htut, Richard A.C. Hughes, Badrul Islam, Zhahirul Islam, Ivonne Jericó‐Pascual, Kenichi Kaida, Summer Karafiath, Hans Katzberg, Mohammad Ali Khoshnoodi, Lynette Kiers, Ruud P. Kleiweg, Norito Kokubun, Noah A. Kolb, Rinske van Koningsveld, Anneke J. van der Kooi, Hans Kramers, Krista Kuitwaard, Justin Y. Kwan, Shafeeq S. Ladha, Lisbeth Landschoff Lassen, Victoria H. Lawson, Helmar Lehmann, Luciana Leon Cejas, Linda Luijten, Michael P.T. Lunn, Fiore Manganelli, Hadi Manji, Girolama A. Marfia, Celedonio Márquez Infante, Lorena Martín‐Aguilar, Eugenia Martinez‐Hernandez, Giorgia Mataluni, Marcelo Mattiazzi, Christopher McDermott, Gregg Meekins, Quazi Deen Mohammad, Soledad Monges, Germán Moris de la Tassa, Caterina Nascimbene, Eduardo Nobile‐Orazio, Richard J. Nowak, Michael Osei‐Bonsu, Julio Pardo, Farah Pelouto, Yann Péreon, Michael T. Pulley, Luis Querol Gutiérrez, Yusuf Rajabally, Stephen W. Reddel, Taco van der Ree, Simon Rinaldi, Paolo Ripellino, Rhys C. Roberts, Iñigo Rojas‐Marcos, Stacy A. Rudnicki, George M. Sachs, Johnny P.A. Samijn, Lucio Santoro, Angelo Schenone, Maria José Sedano Tous, Yukari Sekiguchi, Kazim A. Sheikh, Nicholas Joseph Silvestri, Soeren H. Sundrup, Claudia Sommer, Beth Stein, Mark Stettner, Amro Maher Stino, Robin C.M. Thomma, Paul Twydell, Giovanni Uncini, Jay D. Varrato, Camiel Verhamme, Frederique H. Vermeij, Jan Verschuuren, Leo H. Visser, Michal Vytopil, Christa Walgaard, Min Wang, Yuzhong Wang, Waheed Waqar, Hugh J. Willison, Paul W. Wirtz, Marieke van Woerkom, Sascha A. Zivkovic   +181 more
wiley   +1 more source

Venetoclax as a trigger for autoimmune hemolytic anemia in secondary acute myeloid leukemia: A case report. [PDF]

SAGE Open Med Case Rep
Benallaoua K, Lacoeuilhe P, Gendrot B, Muhammad S, Fouquet G.   +4 more
europepmc   +1 more source

Population Pharmacokinetic Modeling and Exposure‐Response Analyses of Nemtabrutinib in Patients With Hematologic Malignancies

CPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 5, May 2026.
ABSTRACT Nemtabrutinib is a Bruton's tyrosine kinase (BTK) inhibitor under clinical investigation in patients with hematologic malignancies, including chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL). Nemtabrutinib plasma concentration data from 578 patients enrolled in phase 1 and 2 clinical studies, treated with doses from 5 to ...
Chiara C. Kemal, Thijs J. Zweers, Elke H. J. Krekels, Manash S. Chatterjee   +3 more
wiley   +1 more source

Specific Lipidomic Shifts in Chronic Lymphocytic Leukemia at Diagnosis. [PDF]

Cancers (Basel)
Wojnicka J, Kiełbus M, Mertowska P, Mertowski S, Grywalska E, Sosnowski P, Wielgosz A, Kozub-Pędrak A, Sosnowska-Pasiarska B, Klatka M, Klatka J, Błażewicz A.   +11 more
europepmc   +1 more source

Beyond the Usual Suspects: Emerging Associations Between Epstein‐Barr Virus Infection/Infectious Mononucleosis and Cancers

Reviews in Medical Virology, Volume 36, Issue 3, May 2026.
ABSTRACT Epstein‐Barr virus (EBV) is a ubiquitous herpesvirus and a causal factor for Burkitt Lymphoma (BL), Hodgkin Lymphoma (HL), gastric carcinoma (GC) and nasopharyngeal carcinoma (NPC). Whether EBV contributes to a wider spectrum of cancers remains uncertain.
Marisa D. Muckian, Graham S. Taylor, John Diaz‐Decaro, Enejda Senko, Helen R. Stagg   +4 more
wiley   +1 more source

CAR T cells derived from a novel, high-affinity anti-CLL-1 monoclonal antibody exhibit a significant anti-AML effect. [PDF]

Cancer Immunol Immunother
Kida S, Suga M, Yamaguchi Y, Ikeda S, Kogue Y, Kawamoto R, Shibata K, Tsutsumi K, Murakami H, Mizuta E, Mizutani Y, Hosen N.   +11 more
europepmc   +1 more source

Cutaneous non‐tuberculous mycobacterial infections: A retrospective study of 94 cases from Germany

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 5, Page 608-617, May 2026.
Summary Background Cutaneous non‐tuberculous mycobacterial infections (NTM) remain a diagnostic and therapeutic challenge. The aim of this study was to characterize cutaneous NTM infections in Germany over a 24‐year‐period. Patients and Methods 73 patients with cutaneous NTM infections diagnosed at 17 different German University Hospitals from 2000 ...
Luisa Bopp, Nicolai Deresz, Henning Klapproth, Isabelle Suárez, Jonathan Jantsch, Mario Fabri, Esther von Stebut   +6 more
wiley   +1 more source